Fortune 40: Stock picks to retire on

Forty stock picks inspired by the greatest investors of all-time: From the deepest values to solid growth, these shares can make retirement dreams come true.

SNY: The numbers
Market Cap $122.8 billion
Total Return YTD (June 11) 0.2%
Total Return Last 12 Months 2.3%
Earnings Growth (Next Five Years) 6.0%
P/E (Pasts 12 months) 10.9
P/E (Next Year's Estimate) 12.2
Dividend Yield 2.5%
Source: Baseline, as of June 11, 2007.
Foreign Value
The drug maker specializes in heart and cancer ailments and has promising new medicines. Stroke drug Lovenox is its top seller, and sales are rapidly growing for its insulin brand Lantus.

The French pharma giant has managed to grow the franchise for its insomnia drug Ambien, despite a recently-expired patent, largely because of creative patented spin-offs. Sanofi is also trying to get its weight-loss drug Acomplia approved in the U.S.

In addition, the company is a leading vaccine maker in a once-sluggish industry that's ramping up: The U.S. government recently awarded Sanofi a $100 million grant to find a faster way to make bird flu vaccines.
Abbott Labs Johnson & Johnson Coca-Cola Altria Group Colgate General Mills Procter & Gamble Wyeth Accenture AIG Chubb ConocoPhillips McKesson 3M Microsoft United Health Pfizer Aetna Applied Industrial Carpenter Technology Loews Lufkin Tidewater VF Corp. Grey Wolf CSG Systems Hercules K-Swiss Navigant Consulting Park Electrochemical Penn Virginia Plexus UBS Diageo Novartis Petroleo Brasileiro Sanofi-Aventis Total Unilever Vodafone
Bargain hunting for condos The real estate slowdown has made parts of the Sunbelt a lot more affordable. Fortune presents a guide to finding the best deals in five markets. (more)
Retired at 50 Is it possible for someone who doesn't run a hedge fund or win the lottery to retire at 50 (or so)? Yes. (more)
Retirement: Now what?! Think you know what will make you happy? Learn from those who've been there, done that. (more)